Systemic effects of eye medication
55 results
1 - 55
Systemic treatment for blepharokeratoconjunctivitis in children- Interventions for orbital lymphangioma
- Topical medication instillation techniques for glaucoma
- Interventions for preventing ophthalmia neonatorum
- LipiFlow for the treatment of dry eye disease
- Surgical interventions for primary congenital glaucoma
- Non‐biologic, steroid‐sparing therapies for non‐infectious intermediate, posterior, and panuveitis in adults
- Assistive technology for rheumatoid arthritis
- Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis: Cochrane systematic review
- Tumor necrosis factor (TNF) inhibitors for juvenile idiopathic arthritis‐associated uveitis
- Pars plana vitrectomy combined with scleral buckle versus pars plana vitrectomy for giant retinal tear
- Ab interno trabecular bypass surgery with Schlemm´s canal microstent (Hydrus) for open angle glaucoma
- Acupuncture for glaucoma
- Radioiodine therapy versus antithyroid medications for Graves' disease
- Valacyclovir versus acyclovir for the treatment of herpes zoster ophthalmicus in immunocompetent patients
- Automated oxygen delivery for preterm infants with respiratory dysfunction
- Thymectomy for non-thymomatous myasthenia gravis: Cochrane systematic review
- Medical interventions for traumatic hyphema
- Systemic interventions for severe atopic and vernal keratoconjunctivitis in children and young people up to the age of 16 years
- Antimetabolites as an adjunct to dacryocystorhinostomy for nasolacrimal duct obstruction
- Adjunctive modulation of wound healing during cataract surgery to promote survival of a previous trabeculectomy
- Humidification of indoor air for preventing or reducing dryness symptoms or upper respiratory infections in educational settings and at the workplace
- Medical versus surgical interventions for open angle glaucoma
- Interventions for Mooren's ulcer: Cochrane systematic review
- Corticosteroid implants for chronic non‐infectious uveitis
- Interventions for improving adherence to ocular hypotensive therapy
- Medical and surgical treatment for ocular myasthenia
- Thyroid surgery for Graves’ disease and Graves’ ophthalmopathy: Cochrane systematic review
- Topical treatments for blepharokeratoconjunctivitis in children
- Aflibercept for neovascular age‐related macular degeneration
- Anti‐vascular endothelial growth factor for neovascular age‐related macular degeneration
- Interventions for recurrent corneal erosions
- Vestibular rehabilitation for unilateral peripheral vestibular dysfunction: Cochrane systematic review
- Peribulbar versus retrobulbar anaesthesia for cataract surgery
- Psychological therapies for the prevention of migraine in adults
- Anticonvulsants for fibromyalgia: Cochrane systematic review
- Interventions to slow progression of myopia in children
- Sucrose for analgesia in newborn infants undergoing painful procedures
- Routine preoperative medical testing for cataract surgery
- Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis
- Interventions for cutaneous disease in systemic lupus erythematosus
- Visual cycle modulators versus placebo or observation for the prevention and treatment of geographic atrophy due to age‐related macular degeneration
- Exercises for mechanical neck disorders
- Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescents: Cochrane systematic review
- Anti‐vascular endothelial growth factor biosimilars for neovascular age‐related macular degeneration
- Antioxidant vitamin and mineral supplements for preventing age‐related macular degeneration
- Specialist outreach clinics in primary care and rural hospital settings.
- Artificial intelligence for diagnosing exudative age‐related macular degeneration
- Single herbal medicine for diabetic retinopathy